Sinovac Biotech Ltd - ESG Rating & Company Profile powered by AI
Alternative companies in the rating peer group for Sinovac Biotech Ltd are shown below. The analysis of Sinovac Biotech Ltd was prepared by All Street Sevva using leading Cognitive Robots. This ESG rating for Sinovac Biotech Ltd represents the company's transparency towards the United Nations SDGs.
Sinovac Biotech Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Sinovac Biotech Ltd | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sinovac Biotech Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Sinovac Biotech Ltd report the average age of the workforce?
Sign up for free to unlockDoes Sinovac Biotech Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Sinovac Biotech Ltd offer flexible work?
Sign up for free to unlockDoes Sinovac Biotech Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sinovac Biotech Ltd conduct supply chain audits?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sinovac Biotech Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose water use targets?
Sign up for free to unlockDoes Sinovac Biotech Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Sinovac Biotech Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Sinovac Biotech Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sinovac Biotech Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sinovac Biotech Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sinovac Biotech Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sinovac Biotech Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose its waste policy?
Sign up for free to unlockDoes Sinovac Biotech Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose energy use targets?
Sign up for free to unlockDoes Sinovac Biotech Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sinovac Biotech Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sinovac Biotech Ltd
These potential risks are based on the size, segment and geographies of the company.
Sinovac Biotech Ltd., a biopharmaceutical company, focuses in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the People's Republic of China. The company's product portfolio includes vaccines against hepatitis A and B; hand, foot, and mouth diseases caused by enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza; coronavirus; varicella; and mumps. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine to treat viral disease in human species; split viron pandemic influenza vaccine; and Inlive, an EV71 vaccine. The company also offers varicella, a vaccine to treat contagious infectious disease; pneumococcal polysaccharide vaccine, a vaccine to prevent streptococcus pneumoniae infections, such as pneumonia and septicemia; quadrivalent influenza vaccine, a vaccine to protect against two influenza A viruses and two influenza B viruses; and CoronaVac, a vaccine against COVID-19. In addition, its pipeline products include sabin inactivated polio vaccine, a vaccine to treat Poliomyelitis that has completed phase III clinical trial; and rubella vaccine. The company has collaboration agreements with GlaxoSmithKline Biologicals SA to develop combination vaccines containing measles for the China market; Tianjin CanSino Biotechnology Inc. to develop a pneumococcal vaccine; and Instituto Butantan to advance the clinical trials of CoronaVac, an inactivated vaccine candidate against COVID-19 to Phase III. Sinovac Biotech Ltd. was founded in 1993 and is headquartered in Beijing, the People's Republic of China.